| | Webcast | Speakers |
| Keyote presentations | Keynote 1: Artificial Intelligence, to boldly go where no one has gone before | F. Rademakers |
| Keynote 2 – Pharmacist prescribing – from vision to reality | R. Sharma |
| S. Williams* |
| Keynote 3 – Treated by computers? – a futuristic perspective of health care | K. Wac* |
| Student programme | Healthcare professionals’ collaboration as a key to patient-centred care | A. Tonna |
| Seminar CPS1 | Combining centralised and bedside clinical pharmacy | I. Spriet |
| Q&A | S. Antoniou |
| Seminar CPS2 | The role of a hospital pharmacist in addressing health literacy | L. Sahm |
| Q&A | M. Wolf* |
| Seminar CPS3 | Antimicrobial resistance – did we lose the magic bullet? | U. Theuretzbacher |
| Q&A | M. Fellhauer |
| Seminar CPS4 | Good evening pharmacists! Case studies on antimicrobial resistance | I. Urtane |
| J. Lass |
| Q&A | A. von Ameln-Mayerhofer |
| Seminar ER1 | Hospital pharmacy career – by design or left to chance? | H. Farinha |
| Q&A | S. Amann |
| Seminar IG1 | What’s in the crystal ball? – the future of healthcare – HP get ready! | K. M. Pedersen |
| Q&A | L. Tzimis |
| Seminar IG2 | The art of benchmarking | M. Cillis |
| Q&A | E. Estlander* |
| Seminar IG3 | Hospital pharmacists facing new demands – transform your pharmacy team! | A. Weygand |
| H. van Onzenoort |
| Q&A | A. Hogg |
| Interactive session 1 | The pros and cons of telepharmacy | E. Zygadlo-Kozaczuk |
| Q&A | K. McDonald* |
| Interactive session 2 | Chemotherapy dose banding – development and implementation | R. Nuttall |
| Q&A | M. Rasschaert |
| Interactive session 3 | Peri-operative pharmacy services and the enhanced recovery pathway | N. Bansal |
| Q&A | S. Poggio |
| Pharmacotherapy | Pharmacotherapy – COVID19 – Repurposed drugs and treatment | J. Neyts* |
| | S. Pelzl |
| Seminar PC1 | Relax – your 3D printer is doing your work for you | P. van Oirschot* |
| Q&A | T. Hoppe-Tichy* |
| Seminar PC2 | GMP – more than a 3-letter word | K. Froidbise |
| Q&A | K. Schimmel |
| Seminar PSQ1 | Involve patients in improving their care! | P. Barroso Inácio |
| Q&A | B. Dean Franklin |
| Seminar PSQ2 | When Chatbots meet patients and can assist hospital pharmacists! | B. Brouard* |
| Q&A |
| Seminar PSQ3 | Transfer of care – mind the gap | A. Gray |
| S. Daliri |
| Q&A | I. Krämer |
| Seminar SPD1 | New strategies to overcome drug shortages | H. Jenzer* |
| S. Groesser* |
| Q&A | P. Petrou |
| Seminar SPD2 | Medicines for every disease – return on investment vs unmet clinical needs | W-D. Ludwig |
| Q&A | J. Schildmann |
| Workshop 1 | Design your own “Elevator Pitch” – speed dating for hospital pharmacists | J. Hayes |
| Workshop 2 | Critical care multidisciplinary team – the role of the Hospital Pharmacist with a focus on the COVID-19 pandemic | G. Echarri |
| I. Aquerreta |
| Workshop 3 | Clinical prioritisation tools to improve patient care | P. Lewis |
| S. Williams |
| Workshop 4 | Pharmacists – to prescribe or not to prescribe, that is the question… | J. Bateman |
| B. Morath |
| Workshop 5 | Design your career here! | G. Fleming |
| S. Amman |
| Synergy | Oncology biosimilars – Hospital pharmacists making the difference (sponsored by an educational grant from Amgen) | A. Gouveia |
| S. Simoens* |
| Q&A – 23 March | I. Boukovinas* |
| Synergy | Oncology biosimilars – Hospital pharmacists making the difference (sponsored by an educational grant from Amgen) | A. Gouveia |
| S. Simoens* |
| Q&A – 27 March | I. Boukovinas* |
| Synergy | The Hospital Pharmacist’s role in antithrombotic stewardship (sponsored by an educational grant from Bayer) with Paul Wright | P. Wright* |
| Q&A – 23 March |
| Synergy | The Hospital Pharmacist’s role in antithrombotic stewardship (sponsored by an educational grant from Bayer) with Patricia van den Bemt | P. van den Bemt |
| Q&A – 24 March |
| Synergy | Live discussion with faculty: The Hospital Pharmacist’s role in antithrombotic stewardship (sponsored by an educational grant from Bayer) – 28 April | P. Wright* |
| P. van den Bemt |
| Synergy | Biosimilars in colorectal cancer – what’s your gut feeling? (sponsored by an educational grant from Pfizer) | P. Cornes* |
| Q&A – 24 March | T. Tesař |
| Synergy | Biosimilars in colorectal cancer – what’s your gut feeling? (sponsored by an educational grant from Pfizer) | P. Cornes* |
| Q&A – 27 March | T. Tesař |